Vivani Medical, Inc. is a clinical stage company that develops implants that treat chronic diseases with high unmet medical need. Vivani represents the merger of Second Sight Medical Products, Inc. and NanoPrecision Medical, Inc. (NPM).
The Second Sight Division has developed, manufactured, and marketed implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, Second Sight is committed to developing new technologies to treat the broadest population of sight-impaired individuals.
The NPM Division is a near-clinical stage biopharmaceutical company focused on addressing drug non-adherence, a leading reason for poor outcomes in chronic diseases, with miniaturized long-term subdermal implants that are expected to address adherence for the life of the implant and thereby enable existing drugs to achieve their true potential.